TruAlt Bioenergy Ltd (TRUALT) — shareholding pattern, promoter holding, financials and share price
About TruAlt Bioenergy Ltd (TRUALT)
TruAlt Bioenergy Ltd operates in the Other Agricultural Products industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as TRUALT and on the BSE under scrip code 544545. Its ISIN is INE0MWH01014.
Incorporated in 2021, Trualt Bioenergy Limited is engaged in the production of biofuels, with a primary focus on the ethanol sector. [1]
TruAlt Bioenergy Limited is an integrated Indian biofuels company producing first‑generation ethanol, compressed biogas (CBG), extra neutral alcohol, CO2, DDGS and liquid fermented organic manure, while operating a growing biofuel retail network; it is one of India’s largest ethanol producers by installed capacity and holds Oil Marketing Company status enabling downstream retail participation and offtake capture.
For nine months ended December 31, 2025 consolidated total income rose 13.3% to ₹1,187.05 crore and consolidated EBITDA increased ~10% to ₹170.99 crore, while consolidated PBT edged down slightly due to higher finance costs and depreciation tied to recent capex; standalone PAT declined reflecting increased interest and amortisation from the expanded asset base.
Listed peers in Other Agricultural Products: Kaveri Seed Company Ltd, Sanstar Ltd, GRM Overseas Ltd, Chamanlal Setia Exports Ltd, Gulshan Polyols Ltd, AVT Natural Products Ltd.
Valuation & Returns
10 Jul 2026At ₹440.05 a share on 10 Jul 2026, TruAlt Bioenergy Ltd (TRUALT) was valued at a price-to-earnings ratio of 38.93x against an industry P/E of 33.81x and a price-to-book of 4.91x on a book value of ₹89.68 per share as of Mar 2025. Solomo computes return on equity of 12.6% and return on capital employed of 12.47% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 38.93x
- Industry P/E
- 33.81x
- P/B
- 4.91x
- EPS (TTM)
- ₹11.3
- Book value / share
- ₹89.68
- ROE
- 12.6%
- ROCE
- 12.47%
- ROA
- 3.2%
- Debt / equity
- 2.02x
- Dividend yield
- 0%
- EBITDA margin
- 21.78%
- 52-week range
- ₹310.7 – ₹550
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, TruAlt Bioenergy Ltd (TRUALT) reported revenue of ₹1,728 crore, net profit of ₹97 crore and earnings per share of ₹11.19. That compares with revenue of ₹1,908 crore and net profit of ₹147 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹596 crore and net profit ₹61 crore (consolidated).
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue (₹ cr) | 762 | 1,223 | 1,908 | 1,728 |
| Net profit (₹ cr) | 35 | 32 | 147 | 97 |
| EPS (₹) | 5.81 | 5.21 | 20.76 | 11.19 |
| Measure | 1Y |
|---|---|
| Sales growth | 55.94% |
| Profit growth | 360.99% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 70.55% of TruAlt Bioenergy Ltd (TRUALT) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.58% and domestic institutional investors (DII) hold 8.36%. Promoters have pledged 36.9% of their holding. Market capitalisation was ₹3,774 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2025.
Largest disclosed public shareholders in Jun 2026: BANDHAN SMALL CAP FUND 2.77%, INVESCO INDIA SMALLCAP FUND 1.88%, L7 HITECH PRIVATE LIMITED 1.62%, CHARTERED FINANCE & LEASING LIMITED 1.43%, TATA MUTUAL FUND - TATA AGGRESSIVE HYBRID FUND 1.29%, SINGULARITY EQUITY FUND I 1%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 70.55% | 36.9% | 0.58% | 8.36% | 29.45% |
| Mar 2026 | 70.55% | 36.9% | 0.66% | 9.4% | 29.45% |
| Dec 2025 | 70.55% | 36.9% | 0.93% | 7.27% | 29.45% |